Resources by Therapeutic Area
A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
Casaletto KB, Elahi FE, Fitch R, Walters S, Fox E, Staffaroni AM, Bettcher B, Zetterberg H, Karydas A, Rojas JC, Boxer AL and Kramer JH. Cytokine DOI: 10.1016/j.cyto.2018.05.032
Speaker: Dr. Darragh Duffy, Institut Pasteur, ParisModerator: Dr. Jayshan Carpen, Moderator, Nature Research
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr. Jayshan Carpen, Moderator, Nature Research
Single Molecule Array Ultra-Sensitive Cytokine Assays in EDTA Plasma Are Robust and Clinically Feasible
The objective of this study was to clinically validate a new ultra-sensitive immunoassay platform with EDTA plasma patient specimens for eventual translation as a blood-based biomarker in immuno-oncology.
Nanomaterials are beginning to play an important role in the next generation of immunological assays and biosensors, with potential impacts both in research and clinical practice. In this brief review, we highlight two areas in which nanomaterials are already making new and important contributions i…